Peritonectomy and resection of mesentery during visceral-peritoneal debulking (VPD) in patients with stage IIIC-IV ovarian cancer: a phase I-II trial

被引：0
|
作者：
Marchetti, Matteo [1 ]
Noventa, Marco [1 ]
Spagnol, Giulia [1 ]
De Tommasi, Orazio [1 ]
Coldebella, Davide [1 ]
Tamagnini, Matteo [1 ]
Bigardi, Sofia [1 ]
Saccardi, Carlo [1 ]
Tozzi, Roberto [1 ]
机构：
[1] Univ Padua, Padua, Italy
来源：
INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER | 2024年 / 34卷 / SUPPL_1期
关键词：
D O I：
10.1136/ijgc-2024-ESGO.41
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
159
引用
收藏
页码：A34 / A34
页数：1
相关论文
共 50 条
  • [41] Phase I/II Trial of Docetaxel and Carboplatin as a First-Line Therapy in Patients with Stage IV Non-Small-Cell Lung Cancer
    Kensuke Kataoka
    Ryujiro Suzuki
    Hiroyuki Taniguchi
    Yasunobu Noda
    Joe Shindoh
    Syuichi Matsumoto
    Yoshiaki Watanabe
    Kousuke Honda
    Kiyoshi Suzuki
    Kenji Baba
    Kazuyoshi Imaizumi
    Hiroaki Kume
    Yoshinori Hasegawa
    Kenzo Takagi
    Lung, 2006, 184 : 133 - 139
  • [42] A phase I trial of dose-dense (biweekly) carboplatin combined with paclitaxel and pegfilgrastim: A feasibility study in patients with untreated Stage III and IV ovarian tubal or primary peritoneal cancer: A Gynecologic Oncology Group study
    Tiersten, Amy D.
    Sill, Michael W.
    Knight, Danielle
    Muggia, Franco
    Garcia, Agustin A.
    Swensen, Ron
    Warshal, David P.
    Mannel, Robert S.
    Fracasso, Paula M.
    GYNECOLOGIC ONCOLOGY, 2010, 118 (03) : 303 - 307
  • [43] A phase I-II clinical trial to evaluate the safety, pharmacokinetics and efficacy of high dose intravenous ascorbic acid synergy with mEHT in Chinese patients with stage III-IV non-small cell lung cancer
    Ou, J.
    Zhu, X.
    Lu, Y.
    Zhao, C.
    Zhang, H.
    Gui, X.
    Wang, X.
    Zhang, X.
    Zhang, T.
    Pang, C. L. K.
    ANNALS OF ONCOLOGY, 2017, 28
  • [44] Phase I/II trial of the anti-idiotypic monoclonal antibody ACA125 in patients with recurrent epithelial ovarian, fallopian tube or peritoneal cancer.
    Hilpert, F
    Harter, P
    Reinartz, S
    Sehouli, J
    Loibl, S
    Canzler, U
    Belau, A
    Reuss, A
    Jackisch, C
    Pfisterer, J
    JOURNAL OF CLINICAL ONCOLOGY, 2005, 23 (16) : 459S - 459S
  • [45] A phase I/II prospective, single arm trial of gefitinib, trastuzumab, and docetaxel in patients with stage IV HER-2 positive metastatic breast cancer
    Somlo, G.
    Martel, C. L.
    Lau, S. K.
    Frankel, P.
    Ruel, C.
    Gu, L.
    Hurria, A.
    Chung, C.
    Luu, T.
    Morgan, R., Jr.
    Leong, L.
    Koczywas, M.
    McNamara, M.
    Russell, C. A.
    Kane, S. E.
    BREAST CANCER RESEARCH AND TREATMENT, 2012, 131 (03) : 899 - 906
  • [46] A phase I/II prospective, single arm trial of gefitinib, trastuzumab, and docetaxel in patients with stage IV HER-2 positive metastatic breast cancer
    G. Somlo
    C. L. Martel
    S. K. Lau
    P. Frankel
    C. Ruel
    L. Gu
    A. Hurria
    C. Chung
    T. Luu
    R. Morgan
    L. Leong
    M. Koczywas
    M. McNamara
    C. A. Russell
    S. E. Kane
    Breast Cancer Research and Treatment, 2012, 131 : 899 - 906
  • [47] A phase I/II trial of weekly docetaxel and gefitinib in elderly patients (≥ 70) with stage IIIB/IV non-small cell lung cancer (NSCLC).
    Stinchcombe, TE
    Socinski, MA
    Choksi, J
    Bakri, K
    Taylor, M
    Tynan, MT
    Mears, A
    Smith, C
    JOURNAL OF CLINICAL ONCOLOGY, 2005, 23 (16) : 685S - 685S
  • [48] A phase I/II trial of weekly docetaxel and gefitinib in elderly patients (≥70) with stage IIIB/IV non-small cell lung cancer (NSCLC)
    Stinchcombe, T
    Socinski, M
    Choksi, J
    Bakri, K
    Taylor, M
    Tynan, M
    Mears, A
    Smith, C
    LUNG CANCER, 2005, 49 : S270 - S270
  • [49] Comparative phase II study of intraperitoneal (IP) versus intravenous (IV) carboplatin administration with IV paclitaxel in patients with bulky residual disease after primary debulking surgery for epithelial ovarian or primary peritoneal cancer: A Sankai Gynecology Study Group (SGSG) study
    Fujiwara, K.
    Nagao, S.
    Kigawa, J.
    Noma, J.
    Akamatsu, N.
    Miyagi, Y.
    Numa, F.
    Okada, M.
    Aotani, E.
    Terakawa, N.
    JOURNAL OF CLINICAL ONCOLOGY, 2007, 25 (18)
  • [50] A phase I-II clinical trial to evaluate the safety, pharmacokinetics, and efficacy of high-dose intravenous ascorbic acid synergy with mEHT in Chinese patients with stage III-IV non-small cell lung cancer.
    Ou, Junwen
    Zhu, Xinyu
    Lu, Yimin
    Zhao, Changlin
    Zhang, Hongyu
    Zhang, Xinting
    Zhang, Tao
    Pang, Clifford L. K.
    JOURNAL OF CLINICAL ONCOLOGY, 2017, 35
12345